API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-11-2023-46012.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216625
https://www.fiercepharma.com/pharma/novartis-isnt-done-shaking-things-sells-five-eyecare-drugs-harrow-130-million
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212567
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-21-2022-99399.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214181
https://www.prnewswire.com/news-releases/bausch--lomb-announces-scientific-data-on-xipere-triamcinolone-acetonide-injectable-suspension-to-be-presented-during-the-american-society-of-retina-specialists-annual-scientific-meeting-301581017.html
https://health.economictimes.indiatimes.com/news/pharma/aurobindo-pharma-arm-receives-usfda-nod-for-triamcinolone-acetonide-injectable-suspension/92702483
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212400
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-30-2022-1648618596.pdf
https://www.prnewswire.com/news-releases/bausch--lomb-and-clearside-biomedical-announce-the-us-commercial-launch-of-xipere-triamcinolone-acetonide-injectable-suspension-for-suprachoroidal-use-for-the-treatment-of-macular-edema-associated-with-uveitis-301511357.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharmaceuticals-jv-gets-usfda-final-nod-for-anti-fungal-drug/articleshow/90071578.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214186
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213543
https://www.prnewswire.com/news-releases/arctic-vision-announces-first-patient-dosed-in-phase-iii-study-of-arvn001-for-treatment-of-macular-edema-associated-with-uveitis-ume-301429973.html
https://www.expresspharma.in/bausch-and-clearside-biomedical-announce-fda-approval-of-xipere/
https://www.globenewswire.com/news-release/2021/09/09/2294162/0/en/Clearside-Biomedical-Expands-XIPERE-License-Agreement-with-Arctic-Vision-to-Include-Australia-New-Zealand-India-and-ASEAN-Countries.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214751
https://www.prnewswire.com/news-releases/innovent-announces-sintilimab-in-combination-with-chemotherapy-meets-the-primary-endpoint-of-overall-survival-in-the-phase-3-orient-16-study-for-the-first-line-treatment-of-advanced-or-metastatic-gastric-or-gastroesophageal-juncti-301355470.html
https://www.globenewswire.com/news-release/2021/05/12/2228643/29848/en/Flexion-Therapeutics-Reports-First-Quarter-2021-Financial-Results-and-Recent-Business-Updates.html#:~:text=First%2DQuarter%20Results%20%26%20Financial%20Highlights,%2C%202021%20and%202020%2C%20respectively.
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-2-2020-1606885653.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213619
https://www.globenewswire.com/news-release/2020/09/23/2097880/0/en/Clearside-Biomedical-Announces-Clinical-Data-Presentations-at-The-Retina-Society-2020-and-Publication-of-XIPERE-Data-in-Diabetic-Macular-Edema-in-Ophthalmology-Retina.html
https://www.globenewswire.com/news-release/2020/08/24/2082531/0/en/Medexus-Reports-Triamcinolone-Hexacetonide-Injectable-Suspension-Approved-for-Inclusion-on-Quebec-s-RAMQ-List-of-Medications-Basic-Plan-and-Institutions.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213142
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-8-2020-1594182255.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213559
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212356
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-usfda-nod-for-generic-ointment-to-treat-skin-conditions/articleshow/76151188.cms
https://www.globenewswire.com/news-release/2020/04/01/2009879/0/en/Flexion-Therapeutics-Announces-ZILRETTA-License-Agreement-and-Provides-Business-Update-Amid-Coronavirus-Pandemic.html
https://www.prnewswire.com/news-releases/bausch-health-and-clearside-biomedical-announce-publication-of-pivotal-phase-3-data-on-xiperetm-triamcinolone-acetonide-suprachoroidal-injectable-suspension-in-ophthalmology-300994122.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212356
https://www.marketwatch.com/story/flexion-therapeutics-stock-soars-24-premarket-as-fda-approves-label-change-for-oa-keen-pain-therapy-2019-12-27
https://www.pharmacompass.com/pdf/news/farmabios-spa-fails-edqm-inspection-1575005454.pdf
https://endpts.com/clearside-biomedical-predicts-its-uveitis-drug-will-be-rejected-after-fda-requests-more-data/
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=6312019105346
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-subsidiary-sells-assigns-us-rights-for-3-brands-to-encore-dermatology/articleshow/68683488.cms
https://www.biospace.com/article/releases/encore-dermatology-inc-acquires-sernivo-trianex-and-promiseb-/?s=79
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210346
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209828
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2018/68348r-eng.php
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207764
https://endpts.com/clearside-bio-loses-nearly-half-its-value-pre-market-as-lead-eye-drug-fails-pivotal-test/
https://www.fiercebiotech.com/biotech/clearside-slides-as-eye-drug-xipere-flunks-combination-study
https://www.livemint.com/Companies/4PZEkzoLN49OJlBBXLNVjI/Dr-Reddys-Labs-recalls-35000-tubes-of-skin-infection-cream.html
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=910201811531
https://www.prnewswire.com/news-releases/imprimis-announces-multi-center-clinical-trial-for-dropless-trimoxi-triamcinolone-acetonide-moxifloxacin-for-injection-formulation-in-canada-300689876.html